Deutsche Bank’s Biolase, Inc. BIOL Stock Holding History

Deutsche Bank’s Portfolio BIOL Stock Details BIOL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Hold	0	–	–	–	5649
2017 Q4	–	Hold	0	–	–	–	5187
2017 Q3	–	Sell	-6	Closed	-$51.7K	–	5133
2017 Q2	$69K	Sell	6 -1	-14%	-$14.8K	﹤0.01%	4305
2017 Q1	$110K	Sell	7 -3	-30%	-$54.4K	﹤0.01%	3871
2016 Q4	$170K	Buy	10 +1	+11%	+$19.8K	﹤0.01%	3776
2016 Q3	$188K	Buy	9 +3	+50%	+$53.4K	﹤0.01%	3685
2016 Q2	$84K	Hold	6	–	–	﹤0.01%	4187
2016 Q1	$94K	Hold	6	–	–	﹤0.01%	4054
2015 Q4	$61K	Hold	6	–	–	﹤0.01%	4306
2015 Q3	$65K	Hold	6	–	–	﹤0.01%	4316
2015 Q2	$125K	Hold	6	–	–	﹤0.01%	4120
2015 Q1	$145K	Buy	6 +5	+500%	+$142K	﹤0.01%	3961
2014 Q4	$38K	Hold	1	–	–	﹤0.01%	5270
2014 Q3	$24K	Sell	1 -12	-92%	-$339K	﹤0.01%	5147
2014 Q2	$369K	Buy	13 +12	+1,200%	+$306K	﹤0.01%	3711
2014 Q1	$34K	Hold	1	–	–	﹤0.01%	4697
2013 Q4	$18K	Sell	1 -2	-67%	-$47.4K	﹤0.01%	4765
2013 Q3	$76K	Buy	3 +1	+50%	+$32.2K	﹤0.01%	4528
2013 Q2	$67K	Buy	+2	New	+$112K	﹤0.01%	4403

Other funds holding BIOL

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return

TMC

Trellus Management Company Delray Beach, Florida $72.8M AUM 4.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Deutsche Bank's BIOL Position: Q1 2018 in Review

Deutsche Bank held its Biolase, Inc. (BIOL) position steady in Q1 2018 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5649.

Deutsche Bank first reported a position in BIOL in Q2 2013 and has held it in 17 quarters since. The position peaked at $369K in Q2 2014. 26 funds tracked by Wall St. Rank hold BIOL as of Q1 2018.

Deutsche Bank held 0 shares of Biolase, Inc. worth $0 as of Q1 2018.
Deutsche Bank left its Biolase, Inc. share count unchanged in Q1 2018.
Biolase, Inc. made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2018, its #5649 holding.
Deutsche Bank first reported a position in Biolase, Inc. in Q2 2013 and has held it in 17 quarters since.
Deutsche Bank's Biolase, Inc. position peaked at $369K in Q2 2014.
26 funds tracked by Wall St. Rank held Biolase, Inc. as of Q1 2018.

Based on Deutsche Bank's 13F filing for Q1 2018, filed 15 May 2018.